CLINICAL_TRIALS
trial_result
· 2015-01-19
Clinical Trial Update: Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma [Phase 2]
Summary
Phase 2 safety study completed for two applications of PEP005 topical gel in nodular basal cell carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peplin | Conditions: Basal Cell Carcinoma | Phase 2 | Status: COMPLETED